Featured News

The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.

The Celiac Disease in Learning Environments: A Continuing Education Program for Nurses Who Care for Children with Celiac Disease training seminar will complement the recommendations found in the 2020 Voluntary Recommendations for Managing Celiac Disease in Learning Environments.

Registration is open for Virtual Camp Celiac 2021 for children ages 9-17 years old, diagnosed with celiac disease requiring a lifelong strict gluten-free diet.

The Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) study is revealing how genetic and lifestyle factors make children susceptible to autoimmune diseases such as celiac disease, inflammatory bowel disease, and multiple sclerosis.

With your help, we have invested significant resources into changing that reality in Washington, DC, and we are beginning to see a return on that investment.

Thank you to Schär for sponsoring our upcoming Patient Education and Advocacy Summit. For over 35 years, Schär has been dedicated to the celiac and gluten-sensitive communities by providing a safe, flavorful, and quality line of gluten-free products. Learn more about Schär’s collection of gluten-free goods.

Initial findings of the first mass screening study for U.S. children show a high prevalence of celiac disease autoimmunity (CDA) among those without symptoms and no family history of the condition.

I want to share with you highlights of our advocacy plans for 2021. Our work in Washington, DC, with Congress, with the NIH, FDA, and other agencies, is critical in the pursuit of treatments and a cure for celiac disease.

The Senate Appropriations Committee has released their FY2021 funding recommendations, which includes report language directing NIH to support celiac disease research.